Effect of PTH(1-34) Treatment on Fracture Healing in Vivo.

Trial Profile

Effect of PTH(1-34) Treatment on Fracture Healing in Vivo.

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 01 Jul 2015

At a glance

  • Drugs Teriparatide (Primary)
  • Indications Fracture; Postmenopausal osteoporosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Nov 2012 Status changed from not yet recruiting to discontinued as reported by European Clinical Trials Database.
    • 13 Sep 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top